Evidence map›Paper›PMID 16707578›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2006

Attachment of capsular polysaccharide to the cell wall of Streptococcus pneumoniae type 2 is required for invasive disease.

Judy K Morona, Renato Morona, James C Paton

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 65 papers.

0numbers the graph read from it
0cells of the map it votes in
65citing papers in PubMed
3.2field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

65 citing papers in PubMed, 134 citations in OpenAlex.

  1. Article
  2. Microbiology spectrum · 2024
    Article
  3. Article
  4. Article
  5. The bacterial tyrosine kinase system CpsBCD governs the length of capsule polymers.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Microbiology spectrum · 2019
    Review
  14. Article
  15. Article
  16. The LuxS/AI-2 Quorum-Sensing System ofFrontiers in cellular and infection microbiology · 2018
    Article
  17. Article
  18. Article
  19. Article
  20. Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article

5 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Judy K MoronaSchool of Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia 5005, Australia.
Renato Morona
James C Paton
University of Adelaide · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The capacity of Streptococcus pneumoniae to produce capsular polysaccharide (CPS) is essential for virulence. The CPS biosynthesis proteins CpsB, CpsC, and CpsD function to regulate CPS production via tyrosine phosphorylation of CpsD. This mechanism of regulating CPS production is important for enabling S. pneumoniae to cause invasive disease. Here, we identify mutations affecting the attachment of CPS to the cell wall. These mutations were located in cpsC, such that CpsC functioned independently from CpsD tyrosine phosphorylation. These mutants produced WT levels of CPS, but were unable to cause bacteremia in mice after intranasal challenge. This finding suggests that cell-wall attachment of CPS is essential for invasive pneumococcal disease; production of WT levels of CPS alone is not sufficient. We also show that cpsB mutants, which lack the phosphotyrosine-protein phosphatase, produced less CPS than the WT strain, but attached substantially more CPS to their cell wall. Thus, the phosphorylated form of CpsD promotes attachment of CPS to the cell wall.

Indexed as

AnimalsAspartic AcidBacterial ProteinsCell Line, TumorCell WallDrug Resistance, BacterialErythromycinHumansMembrane FusionMiceMutationPneumococcal InfectionsPolysaccharides, BacterialProtein-Tyrosine KinasesProtein Tyrosine PhosphatasesStreptococcus pneumoniaeAspartic AcidBacterial ProteinsCpsA protein, Streptococcus pneumoniaeCpsB protein, Streptococcus pneumoniaeCpsD protein, Streptococcus pneumoniaeErythromycinPolysaccharides, BacterialProtein-Tyrosine KinasesProtein Tyrosine PhosphatasesTetracycline

Identifiers

PMID16707578
PMCPMC1482522
OpenAlexW2113099409

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.